PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Track Record
Showing latest 4 periods • Swipe for more
Metric
2025
2024
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue
2.86B
2.76B
3.31B
5.07B
3.78B
2.88B
2.78B
2.26B
2.12B
2.26B
2.24B
2.17B
Net Income
241.20M
270.38M
579.18M
932.16M
727.89M
227.56M
237.93M
292.63M
234.30M
212.43M
157.78M
164.81M
EPS
2.07
2.23
4.59
8.12
6.52
2.06
2.13
2.67
2.14
1.89
1.40
1.49
Free Cash Flow
515.43M
578.31M
594.18M
1.31B
814.67M
282.14M
217.78M
249.36M
318.91M
257.47M
252.53M
119.60M
FCF / Share
4.42
4.76
4.71
11.28
7.31
2.55
1.97
2.27
2.91
2.29
2.24
1.07
Operating CF
588.96M
664.96M
679.81M
1.41B
892.18M
363.47M
311.04M
288.45M
350.62M
287.10M
281.60M
158.59M
Total Assets
12.17B
12.39B
14.13B
15.02B
8.01B
6.54B
5.98B
6.09B
4.28B
4.14B
4.13B
3.95B
Total Debt
3.37B
3.30B
4.56B
5.17B
2.18B
2.22B
1.89B
2.01B
1.05B
1.01B
1.05B
934.73M
Cash & Equiv
919.86M
1.16B
454.36M
618.32M
402.04M
191.88M
163.11M
202.13M
359.26M
237.93M
174.82M
173.24M
Book Value
7.25B
7.67B
7.39B
7.13B
3.74B
2.81B
2.58B
2.50B
2.15B
2.11B
2.04B
1.99B
Return on Equity
0.03
0.04
0.08
0.13
0.19
0.08
0.09
0.12
0.11
0.10
0.08
0.08
Metric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Revenue
729.69M
711.12M
772.06M
698.95M
720.28M
664.76M
608.12M
563.44M
563.91M
526.90M
608.39M
542.05M
Net Income
51.82M
40.72M
98.36M
46.65M
53.95M
42.24M
68.25M
54.86M
48.97M
40.33M
30.79M
42.28M
EPS
0.47
0.36
0.87
0.40
0.46
0.35
0.61
0.49
0.43
0.36
0.27
0.38
Free Cash Flow
180.87M
106.11M
161.79M
120.08M
121.39M
118.11M
113.42M
53.01M
57.85M
33.18M
89.71M
55.16M
FCF / Share
1.62
0.95
1.43
1.02
1.03
0.98
1.01
0.47
0.51
0.29
0.80
0.49
Operating CF
191.94M
125.89M
181.96M
138.58M
140.26M
134.10M
125.24M
60.73M
63.47M
37.66M
96.56M
62.93M
Total Assets
12.05B
12.00B
12.17B
12.14B
12.36B
12.36B
4.14B
4.03B
4.08B
4.03B
4.13B
3.89B
Total Debt
3.34B
3.35B
3.37B
3.37B
3.37B
3.33B
1.01B
1.03B
988.43M
1.02B
1.05B
859.74M
Cash & Equiv
1.02B
860.32M
919.86M
931.39M
991.85M
1.14B
237.93M
195.07M
192.17M
168.92M
174.82M
203.68M
Book Value
7.23B
7.18B
7.25B
7.38B
7.56B
7.64B
2.11B
2.05B
2.12B
2.06B
2.04B
2.06B
Return on Equity
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.03
0.02
0.02
0.02
0.02
PKI News
No news available for PKI.
Log out?
You will be signed out of AlphaMadera on this device.